Brief: Annexin Pharmaceuticals Q3 Net Loss Widens To SEK 4.8 Million
Oct 31 (Reuters) - Annexin Pharmaceuticals AB (publ)
ANNX.ST :
* Q3 NET LOSS SEK 4.8 MILLION VERSUS LOSS SEK 3.8 MILLION
YEAR AGO
Source text for Eikon: ID:nWkr511NfR
Further company coverage: ANNX.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 587720920;))
Recent news on Annexin Pharmaceuticals AB (publ)
See all newsBrief: Annexin Pharmaceuticals Q3 Net Loss At SEK 9.5 Mln
Brief: Annexin Pharmaceuticals Q2 2026 Net Loss SEK 11.6 Mln
Brief: Annexin Pharmaceuticals Gets International Nonproprietary Name Drug Candidate Anxv
Brief: Annexin Pharmaceuticals Updates On Nine Patients Treated In Nexus Study
Brief: Annexin's Rights Issue 98% Subscribed